Microarray analysis of bone marrow-derived macrophage cells treated with Kdo2-lipid A (KLA) and ATP

Search by fold change ratio | Search by KEGG pathway | Search by LIPID MAPS lipid pathway

Kdo2-Lipid A / ATP gene array data - treatment:control ratios

KEGG pathway: Staphylococcus aureus infection (mmu05150)

Legend:graph_icon: View data/graphs for replicates
Gene symbol    Time course plot Accession Description Treatment 15min 30min 1hr 2hr 4hr 8hr 20hr
C1qa
KLA  ATP  ATP+KLA
 NM_007572 complement component 1, q subcomponent, alpha polypeptide (C1qa), mRNA [NM_007572] KLA 1.12 1.11 1.09 .94 1.11 1.12 1.31
ATP 1.14 1.21 .88 1.16 .90 .67 .95
KLA/ATP 1.12 1.23 .93 1.27 .86 .81 .91
C1qb
KLA  ATP  ATP+KLA
 NM_009777 complement component 1, q subcomponent, beta polypeptide (C1qb), mRNA [NM_009777] KLA 1.01 1.14 1.20 1.15 1.31 1.15 1.06
ATP 1.16 1.20 .84 1.27 1.02 .70 .76
KLA/ATP 1.29 1.36 .95 1.28 1.00 .97 .85
C1qc
KLA  ATP  ATP+KLA
 NM_007574 complement component 1, q subcomponent, C chain (C1qc), mRNA [NM_007574] KLA 1.03 .97 1.01 1.04 1.07 1.13 1.15
ATP 1.07 1.06 .91 .94 .77 .62 .82
KLA/ATP 1.08 1.02 .95 1.04 .76 .73 .66
C1r
KLA  ATP  ATP+KLA
 NM_023143 complement component 1, r subcomponent (C1r), mRNA [NM_023143] KLA 8.09 7.91 7.94 8.52 7.04 6.64 3.85
ATP .96 .88 1.02 .92 .86 1.28 1.82
KLA/ATP 7.33 7.67 7.74 6.90 4.82 3.90 3.88
C1s
KLA  ATP  ATP+KLA
 NM_144938 complement component 1, s subcomponent (C1s), transcript variant 1, mRNA [NM_144938] KLA 1.32 1.25 1.42 1.28 1.26 1.18 1.22
ATP 1.00 1.04 1.04 1.06 1.02 1.12 1.21
KLA/ATP 1.34 1.30 1.19 1.19 1.15 1.18 1.21
C2
KLA  ATP  ATP+KLA
 NM_013484 complement component 2 (within H-2S) (C2), mRNA [NM_013484] KLA 1.84 2.05 2.15 2.41 2.47 2.93 3.16
ATP .96 .96 1.22 1.18 1.15 1.16 1.42
KLA/ATP 1.81 2.00 2.25 1.92 1.84 2.10 2.96
C3
KLA  ATP  ATP+KLA
 NM_009778 complement component 3 (C3), mRNA [NM_009778] KLA 28.58 25.57 24.39 27.34 23.38 23.21 18.10
ATP 1.04 .93 1.21 1.90 2.80 5.74 12.19
KLA/ATP 27.04 26.10 33.29 23.09 25.65 23.77 40.22
C3ar1
KLA  ATP  ATP+KLA
 NM_009779 complement component 3a receptor 1 (C3ar1), mRNA [NM_009779] KLA .93 1.01 1.03 1.20 1.34 1.60 1.59
ATP 1.03 1.13 .81 .99 .72 .48 1.44
KLA/ATP 1.06 1.02 .77 .99 .81 .85 1.20
C4b
KLA  ATP  ATP+KLA
 NM_009780 complement component 4B (Childo blood group) (C4b), mRNA [NM_009780] KLA 1.46 1.50 1.67 1.58 1.87 1.68 1.33
ATP 1.05 .99 .95 .87 .88 .79 .66
KLA/ATP 1.39 1.62 1.52 1.32 1.36 1.03 .73
C5ar1
KLA  ATP  ATP+KLA
 NM_007577 complement component 5a receptor 1 (C5ar1), mRNA [NM_007577] KLA 1.10 1.18 1.09 .81 .64 .49 .83
ATP 1.07 1.30 1.02 2.07 .92 .48 1.75
KLA/ATP 1.24 1.32 .83 1.58 .69 .46 .85
Cfb
KLA  ATP  ATP+KLA
 NM_008198 complement factor B (Cfb), mRNA [NM_008198] KLA 17.72 17.63 19.57 22.37 22.31 26.39 22.71
ATP .99 .94 1.17 1.19 1.32 7.30 13.25
KLA/ATP 16.12 18.46 25.42 23.14 22.30 25.87 31.46
Cfd
KLA  ATP  ATP+KLA
 NM_013459 complement factor D (adipsin) (Cfd), mRNA [NM_013459] KLA .97 .95 1.04 1.01 1.02 .95 1.08
ATP 1.03 1.00 1.10 1.00 .99 .95 .98
KLA/ATP 1.07 1.05 1.05 .93 .97 1.09 .93
Cfh
KLA  ATP  ATP+KLA
 M12660 gb|Mouse CFh locus, complement protein H gene, complete cds, clones MH(4,8). [M12660] KLA .84 .95 .90 .70 .58 .32 .13
ATP 1.11 1.46 1.17 1.10 .72 .44 .17
KLA/ATP .98 1.00 .86 .90 .53 .36 .14
Cfh
KLA  ATP  ATP+KLA
 NM_009888 complement component factor h (Cfh), mRNA [NM_009888] KLA .86 .82 .81 .66 .43 .21 .07
ATP 1.00 .98 1.37 .95 .65 .41 .11
KLA/ATP .83 .83 .96 .71 .46 .25 .07
Cfi
KLA  ATP  ATP+KLA
 NM_007686 complement component factor i (Cfi), mRNA [NM_007686] KLA .95 1.00 1.03 1.02 1.06 1.03 1.00
ATP .96 .94 .97 1.03 1.11 1.06 1.06
KLA/ATP 1.00 1.00 1.07 1.01 1.08 1.08 1.05
Dsg1a
KLA  ATP  ATP+KLA
 NM_010079 desmoglein 1 alpha (Dsg1a), mRNA [NM_010079] KLA .93 1.01 1.02 .96 1.00 1.03 .98
ATP 1.06 .93 1.01 1.12 1.02 1.02 1.03
KLA/ATP 1.05 .98 .99 1.01 1.09 1.03 .97
Dsg1b
KLA  ATP  ATP+KLA
 NM_181682 desmoglein 1 beta (Dsg1b), mRNA [NM_181682] KLA 1.02 1.02 1.01 .98 1.00 1.00 .98
ATP .99 1.06 .99 1.04 .98 1.01 .94
KLA/ATP 1.00 1.04 1.01 .97 .97 .97 .97
Dsg1c
KLA  ATP  ATP+KLA
 AK034104 adult male diencephalon cDNA, RIKEN full-length enriched library, clone:9330156N18 product:similar to DESMOGLEIN 1 PRECURSOR (DESMOSOMAL GLYCOPROTEIN 1) (DG1) (DGI) (PEMPHIGUS FOLIACEUS ANTIGEN) [Homo sapiens], full insert sequence [AK034 KLA 1.02 1.01 1.04 1.04 1.05 1.02 1.05
ATP 1.05 .93 .95 1.14 1.06 .99 .97
KLA/ATP 1.10 .98 1.00 1.01 1.10 1.01 .97
EG317677
KLA  ATP  ATP+KLA
 NM_173864 predicted gene, EG317677 (EG317677), mRNA [NM_173864] KLA .99 .99 1.01 1.01 .97 .98 1.06
ATP 1.00 1.01 1.05 1.05 .98 .99 1.01
KLA/ATP 1.00 1.00 .99 1.02 1.01 1.01 1.02
EG629860
KLA  ATP  ATP+KLA
 M17953 gb|Mouse Ig rearranged H-chain V-region mRNA VJ1 [M17953] KLA .96 1.05 1.03 1.08 1.08 1.02 .98
ATP .97 .99 1.05 1.10 .95 .94 .91
KLA/ATP .96 .94 .97 1.04 .97 1.01 .89
Fcgr1
KLA  ATP  ATP+KLA
 AF143181 strain AB/H (Biozzi) high affinity immunoglobulin gamma Fc receptor I (Fcgr1) mRNA, Fcgr1-d allele, complete cds. [AF143181] KLA 4.27 4.21 5.59 6.14 8.13 9.76 10.98
ATP 1.23 1.12 1.08 1.36 1.09 2.09 11.81
KLA/ATP 4.56 4.93 4.95 5.88 6.66 9.64 23.09
Fcgr1
KLA  ATP  ATP+KLA
 NM_010186 Fc receptor, IgG, high affinity I (Fcgr1), mRNA [NM_010186] KLA 4.31 4.37 4.70 5.97 6.59 10.06 8.67
ATP 1.01 .88 1.16 .89 .90 2.15 9.23
KLA/ATP 4.01 4.10 5.52 4.54 6.31 9.24 15.83
Fcgr2b
KLA  ATP  ATP+KLA
 NM_001077189 Fc receptor, IgG, low affinity IIb (Fcgr2b), transcript variant 1, mRNA [NM_001077189] KLA 16.93 17.57 21.75 27.43 34.13 31.88 5.70
ATP 1.11 1.09 1.17 1.46 2.81 11.26 1.92
KLA/ATP 16.51 17.91 23.67 29.22 22.67 25.33 9.54
Fcgr2b
KLA  ATP  ATP+KLA
 NM_010187 Fc receptor, IgG, low affinity IIb (Fcgr2b), transcript variant 2, mRNA [NM_010187] KLA 11.41 11.67 14.06 15.47 17.28 18.63 4.69
ATP 1.05 1.06 1.18 1.57 2.27 8.97 2.10
KLA/ATP 10.98 12.01 15.03 18.38 15.15 16.00 8.33
Fcgr3
KLA  ATP  ATP+KLA
 NM_010188 Fc receptor, IgG, low affinity III (Fcgr3), mRNA [NM_010188] KLA 1.35 1.47 1.87 1.77 2.39 2.34 1.13
ATP 1.04 1.10 .99 1.14 1.01 1.55 1.90
KLA/ATP 1.50 1.53 1.53 1.99 1.61 2.38 2.69
Fcgr4
KLA  ATP  ATP+KLA
 NM_144559 Fc receptor, IgG, low affinity IV (Fcgr4), mRNA [NM_144559] KLA 9.03 8.68 9.82 11.51 11.12 13.01 7.95
ATP 1.04 .95 1.22 1.43 1.17 2.80 4.48
KLA/ATP 8.63 8.84 11.99 11.84 12.40 13.56 12.31
Fgg
KLA  ATP  ATP+KLA
 NM_133862 fibrinogen, gamma polypeptide (Fgg), mRNA [NM_133862] KLA 1.01 1.00 .96 1.02 .99 1.01 1.07
ATP .97 .94 1.00 1.03 1.00 1.08 1.08
KLA/ATP .96 1.00 .98 1.01 .98 1.06 1.01
Fpr1
KLA  ATP  ATP+KLA
 NM_013521 formyl peptide receptor 1 (Fpr1), mRNA [NM_013521] KLA 12.54 11.98 13.69 17.91 17.62 21.59 20.02
ATP 1.09 1.02 1.66 1.90 2.46 10.47 6.95
KLA/ATP 10.93 13.61 16.67 13.71 13.37 13.41 21.96
Fpr2
KLA  ATP  ATP+KLA
 NM_008039 formyl peptide receptor 2 (Fpr2), mRNA [NM_008039] KLA 30.10 32.49 33.82 36.00 37.31 42.10 32.37
ATP 1.10 1.05 1.45 1.72 2.69 13.48 7.36
KLA/ATP 27.60 31.79 38.83 33.94 35.28 33.33 38.38
H2-Aa
KLA  ATP  ATP+KLA
 NM_010378 histocompatibility 2, class II antigen A, alpha (H2-Aa), mRNA [NM_010378] KLA 1.43 1.59 1.68 1.50 1.62 1.89 1.64
ATP 1.07 1.15 1.27 1.90 1.92 1.77 1.55
KLA/ATP 1.62 1.81 1.74 2.29 1.89 1.92 2.19
H2-Ab1
KLA  ATP  ATP+KLA
 BC010322 histocompatibility 2, class II antigen A, beta 1, mRNA (cDNA clone MGC:6297 IMAGE:2651058), complete cds [BC010322] KLA 1.73 1.76 1.77 1.55 1.95 2.10 2.27
ATP 1.03 1.18 1.32 1.99 1.79 1.56 1.61
KLA/ATP 1.70 2.01 1.74 2.52 1.58 2.01 2.75
H2-Ab1
KLA  ATP  ATP+KLA
 NM_207105 histocompatibility 2, class II antigen A, beta 1 (H2-Ab1), mRNA [NM_207105] KLA 2.02 2.15 2.07 2.09 2.32 2.78 3.08
ATP 1.11 1.20 1.42 2.33 2.33 2.25 1.87
KLA/ATP 2.11 2.32 2.52 3.62 2.67 2.96 5.04
H2-DMa
KLA  ATP  ATP+KLA
 NM_010386 histocompatibility 2, class II, locus DMa (H2-DMa), mRNA [NM_010386] KLA 1.49 1.50 1.65 1.65 1.91 2.23 1.69
ATP 1.04 1.12 1.26 1.67 1.24 .99 1.32
KLA/ATP 1.58 1.68 1.70 2.02 1.37 1.35 1.90
H2-DMb1
KLA  ATP  ATP+KLA
 NM_010387 histocompatibility 2, class II, locus Mb1 (H2-DMb1), mRNA [NM_010387] KLA 1.06 1.14 1.08 1.13 1.24 1.41 1.37
ATP 1.01 1.02 1.09 1.14 .92 .73 1.36
KLA/ATP 1.13 1.05 1.21 1.17 .98 .83 1.41
H2-DMb2
KLA  ATP  ATP+KLA
 NM_010388 histocompatibility 2, class II, locus Mb2 (H2-DMb2), mRNA [NM_010388] KLA 1.00 1.04 .93 .95 .96 .95 1.03
ATP 1.06 1.04 .94 .92 .97 .95 1.00
KLA/ATP .90 .94 .99 .94 .90 .96 .92
H2-Eb1
KLA  ATP  ATP+KLA
 X52641 gb|Mouse mRNA for I-A beta NOD. [X52641] KLA 1.94 2.06 1.94 1.87 1.96 2.18 1.76
ATP 1.11 1.20 1.53 2.70 3.02 2.91 1.40
KLA/ATP 2.09 2.11 2.26 3.55 2.76 3.05 3.05
H2-Oa
KLA  ATP  ATP+KLA
 NM_008206 histocompatibility 2, O region alpha locus (H2-Oa), mRNA [NM_008206] KLA 1.22 1.32 1.37 1.33 1.31 1.26 1.53
ATP 1.02 1.05 1.16 1.21 1.12 1.07 1.16
KLA/ATP 1.32 1.34 1.31 1.34 1.25 1.35 2.78
H2-Ob
KLA  ATP  ATP+KLA
 NM_010389 histocompatibility 2, O region beta locus (H2-Ob), mRNA [NM_010389] KLA 1.05 1.07 1.01 .96 1.10 1.02 1.00
ATP 1.04 .99 1.00 1.03 .94 1.07 .94
KLA/ATP 1.02 .97 1.06 1.08 1.00 .96 1.05
Hc
KLA  ATP  ATP+KLA
 NM_010406 hemolytic complement (Hc), mRNA [NM_010406] KLA 1.07 1.12 1.05 .98 1.12 1.12 1.08
ATP .96 .93 1.12 1.07 1.34 5.60 1.48
KLA/ATP 1.05 1.18 1.12 1.05 1.13 3.40 4.37
Icam1
KLA  ATP  ATP+KLA
 BC008626 intercellular adhesion molecule, mRNA (cDNA clone MGC:6195 IMAGE:3588949), complete cds [BC008626] KLA 36.67 32.93 28.63 27.91 14.65 8.16 4.15
ATP .96 .88 1.50 3.88 4.98 3.90 1.01
KLA/ATP 32.58 31.60 42.74 32.60 26.00 13.02 6.01
Icam1
KLA  ATP  ATP+KLA
 NM_010493 intercellular adhesion molecule 1 (Icam1), mRNA [NM_010493] KLA 15.66 15.20 12.96 12.31 9.39 6.17 3.81
ATP .96 1.06 1.21 4.19 4.33 3.16 1.06
KLA/ATP 14.31 15.46 17.84 17.60 13.77 8.36 5.42
Igh-VJ55
8
KLA  ATP  ATP+KLA
 AY547436 immunoglobulin heavy chain VDJ region mRNA, partial cds [AY547436] KLA 1.06 1.05 1.01 .93 1.03 .96 .93
ATP .99 1.00 1.06 .95 .96 1.06 1.05
KLA/ATP .98 .94 1.07 .95 .97 .99 1.02
Igh-VJ55
8
KLA  ATP  ATP+KLA
 CA578712 gb|K0727F04-5N NIA Mouse Hematopoietic Stem Cell (Lin- [CA578712] KLA .99 .94 1.01 1.10 .93 .97 .92
ATP .93 1.04 1.01 .98 1.05 .96 .95
KLA/ATP .99 .95 .95 .98 1.02 .98 .95
Igh-VJ55
8
KLA  ATP  ATP+KLA
 ENSMUST00000103412 ens|Immunoglobulin heavy chain C gene segment [Source:IMGT/GENE_DB;Acc:IGHA] [ENSMUST00000103412] KLA 1.01 .97 1.20 1.01 .98 1.44 1.24
ATP .99 .98 1.07 1.03 1.00 1.01 1.21
KLA/ATP .99 1.02 .96 1.03 .97 1.13 1.30
Igh-VJ55
8
KLA  ATP  ATP+KLA
 ENSMUST00000103413 ens|Immunoglobulin heavy chain C gene segment [Source:IMGT/GENE_DB;Acc:IGHE] [ENSMUST00000103413] KLA 1.00 .99 1.06 1.06 .99 1.03 1.02
ATP 1.08 1.06 1.06 1.06 1.02 1.06 .95
KLA/ATP 1.00 1.04 1.09 1.02 1.06 1.02 .95
Igh-VJ55
8
KLA  ATP  ATP+KLA
 U39781 J558+ IgM heavy chain mRNA, hybridoma clone ME2B7, partial cds. [U39781] KLA .93 .89 .98 .97 1.03 1.00 .94
ATP 1.04 1.02 1.08 .94 .93 .90 .79
KLA/ATP .88 .89 .97 .93 .88 .92 .82
Il10
KLA  ATP  ATP+KLA
 NM_010548 interleukin 10 (Il10), mRNA [NM_010548] KLA 17.59 18.64 22.22 23.06 11.83 8.27 2.07
ATP 1.86 3.22 7.72 20.51 25.86 8.38 1.01
KLA/ATP 17.91 23.49 34.53 34.48 20.98 12.03 8.17
Itgal
KLA  ATP  ATP+KLA
 AK156251 activated spleen cDNA, RIKEN full-length enriched library, clone:F830013L17 product:integrin alpha L, full insert sequence [AK156251] KLA 5.36 5.78 4.86 5.55 7.02 8.63 11.12
ATP .99 1.17 1.22 1.57 1.35 1.95 3.79
KLA/ATP 5.42 5.89 4.95 5.91 3.96 4.93 10.15
Itgal
KLA  ATP  ATP+KLA
 NM_008400 integrin alpha L (Itgal), mRNA [NM_008400] KLA 4.48 5.17 5.28 5.82 7.82 8.09 16.96
ATP 1.03 1.06 1.24 1.44 1.34 2.02 4.59
KLA/ATP 4.71 5.63 5.49 5.60 3.66 4.65 17.76
Itgam
KLA  ATP  ATP+KLA
 NM_001082960 integrin alpha M (Itgam), transcript variant 1, mRNA [NM_001082960] KLA 1.04 1.12 1.14 1.07 1.54 1.80 1.72
ATP 1.17 1.19 .97 1.16 .86 .65 1.33
KLA/ATP 1.19 1.19 .94 1.06 .64 .59 1.08
Itgam
KLA  ATP  ATP+KLA
 NM_008401 integrin alpha M (Itgam), transcript variant 2, mRNA [NM_008401] KLA 1.20 1.16 1.21 1.34 1.59 1.79 1.64
ATP 1.15 1.16 .94 1.20 1.00 .78 1.25
KLA/ATP 1.32 1.37 1.29 1.14 .84 .75 1.16
Itgb2
KLA  ATP  ATP+KLA
 NM_008404 integrin beta 2 (Itgb2), mRNA [NM_008404] KLA .78 .78 .97 .74 1.04 .94 1.14
ATP 1.24 1.23 .79 .95 1.12 .84 1.10
KLA/ATP .99 1.01 .60 .83 .78 .73 .99
Itgb2l
KLA  ATP  ATP+KLA
 NM_008405 integrin beta 2-like (Itgb2l), mRNA [NM_008405] KLA .87 .98 .98 1.00 1.05 1.07 1.10
ATP 1.24 1.23 1.13 1.14 1.29 1.05 1.05
KLA/ATP 1.02 1.08 1.08 1.06 .98 .93 .95
Krt10
KLA  ATP  ATP+KLA
 NM_010660 keratin 10 (Krt10), mRNA [NM_010660] KLA 1.01 .98 1.04 1.04 1.01 .98 1.03
ATP 1.01 1.03 1.02 1.03 .97 .96 .98
KLA/ATP 1.00 .95 1.04 1.02 1.00 .95 .96
Krt10
KLA  ATP  ATP+KLA
 V00830 gb|Mouse mRNA encoding epidermal keratin subunit. [V00830] KLA .91 .81 .83 .99 .90 .94 .97
ATP .86 .97 1.38 1.40 1.31 1.38 .86
KLA/ATP .80 .82 1.09 1.05 1.12 1.20 .94
Masp1
KLA  ATP  ATP+KLA
 AK031598 13 days embryo male testis cDNA, RIKEN full-length enriched library, clone:6030458D19 product:mannan-binding lectin serine protease 1, full insert sequence. [AK031598] KLA .98 .96 1.11 1.00 1.10 1.12 1.12
ATP 1.02 1.01 .99 .97 .99 1.05 1.40
KLA/ATP .96 .93 1.04 1.00 1.04 1.41 1.93
Masp1
KLA  ATP  ATP+KLA
 NM_008555 mannan-binding lectin serine peptidase 1 (Masp1), mRNA [NM_008555] KLA 1.02 1.05 1.01 1.00 .98 1.04 .96
ATP 1.04 .98 .92 1.06 .98 .93 .98
KLA/ATP 1.04 1.06 1.01 .98 1.06 .96 1.04
Masp2
KLA  ATP  ATP+KLA
 NM_001003893 mannan-binding lectin serine peptidase 2 (Masp2), transcript variant 1, mRNA [NM_001003893] KLA 1.01 .97 .99 .94 1.00 .93 1.00
ATP .99 .93 .98 1.01 .96 .90 1.06
KLA/ATP .92 1.00 .99 .98 .99 .97 .97
Masp2
KLA  ATP  ATP+KLA
 NM_010767 mannan-binding lectin serine peptidase 2 (Masp2), transcript variant 2, mRNA [NM_010767] KLA .71 .71 .68 .65 .64 .63 .59
ATP 1.02 1.10 .94 .98 .73 .70 .70
KLA/ATP .73 .68 .67 .72 .65 .59 .65
Mbl1
KLA  ATP  ATP+KLA
 NM_010775 mannose binding lectin (A) (Mbl1), mRNA [NM_010775] KLA .97 1.06 .97 1.03 1.02 .99 .98
ATP 1.05 1.03 .95 1.00 .97 .93 .98
KLA/ATP 1.12 1.00 1.07 1.04 .92 1.02 .94
Mbl2
KLA  ATP  ATP+KLA
 NM_010776 mannose binding lectin (C) (Mbl2), mRNA [NM_010776] KLA 1.04 1.00 1.02 .96 .97 1.00 .96
ATP .98 1.00 .98 .93 .97 .93 .98
KLA/ATP 1.04 1.06 .99 .98 1.02 .94 1.05
Mm.2408
KLA  ATP  ATP+KLA
 147904678 Unknown KLA .92 .85 1.02 1.30 1.31 1.65 1.62
ATP .92 .87 .90 .60 .44 .36 1.61
KLA/ATP .87 .78 .82 .60 .66 .59 1.06
Mm.47319
5
KLA  ATP  ATP+KLA
 124358929 Unknown KLA 1.13 1.14 1.12 1.11 1.06 1.03 1.01
ATP 1.05 1.01 .94 1.06 1.06 1.04 .98
KLA/ATP 1.15 1.14 1.20 1.15 1.06 .93 1.01
Mm.874
KLA  ATP  ATP+KLA
 6754317 Unknown KLA 24.98 24.87 26.43 39.61 12.88 8.64 1.63
ATP 1.97 3.50 11.05 28.47 38.30 10.44 .65
KLA/ATP 23.45 29.37 58.52 51.77 30.64 14.61 8.63
Plg
KLA  ATP  ATP+KLA
 NM_008877 plasminogen (Plg), mRNA [NM_008877] KLA 1.02 1.05 1.06 1.02 1.01 1.09 1.07
ATP .99 .96 1.07 1.08 1.02 .95 1.09
KLA/ATP 1.09 .98 .98 1.09 1.21 1.08 1.04
Ptafr
KLA  ATP  ATP+KLA
 AF004858 platelet activating factor receptor mRNA, partial cds. [AF004858] KLA 1.20 1.24 1.22 1.15 1.15 1.23 1.40
ATP 1.03 1.05 1.04 1.19 1.37 1.33 1.63
KLA/ATP 1.28 1.33 1.17 1.25 1.29 1.50 1.90
Ptafr
KLA  ATP  ATP+KLA
 NM_001081211 platelet-activating factor receptor (Ptafr), mRNA [NM_001081211] KLA 1.73 1.73 1.60 1.31 1.61 1.84 2.08
ATP 1.06 1.10 .98 1.24 2.12 2.22 3.21
KLA/ATP 1.93 1.99 1.47 1.65 1.83 2.58 5.06
Selp
KLA  ATP  ATP+KLA
 NM_011347 selectin, platelet (Selp), mRNA [NM_011347] KLA 1.34 1.37 1.61 1.53 1.59 1.28 1.06
ATP .98 1.00 1.07 1.10 1.11 1.68 1.10
KLA/ATP 1.37 1.45 1.44 1.34 1.22 1.37 1.46
Selplg
KLA  ATP  ATP+KLA
 NM_009151 selectin, platelet (p-selectin) ligand (Selplg), mRNA [NM_009151] KLA .98 1.02 1.18 1.25 1.68 1.74 1.24
ATP 1.17 1.26 .95 1.30 1.02 .72 1.21
KLA/ATP 1.06 1.15 .93 1.28 1.10 1.04 1.69